Insider Trading April 21, 2026 04:43 PM

TransDigm Director Disposes $12.8M in Shares After Option Exercises

W. Nicholas Howley’s family trust exercised options and sold 10,132 shares the same day; company activity includes acquisitions and new debt issuances

By Nina Shah TDG
TransDigm Director Disposes $12.8M in Shares After Option Exercises
TDG

W. Nicholas Howley, a TransDigm Group director, sold 10,132 shares through his family trust on April 20, 2026, generating roughly $12.8 million after exercising options for the same number of shares. The transactions leave the trust holding 21,547.513 shares. The company has reported preliminary quarterly results, completed multiple acquisitions, and issued new debt to support further strategic activity.

Key Points

  • Director W. Nicholas Howley exercised options and sold 10,132 TransDigm shares on April 20, 2026, through the W. Nicholas Howley Family Trust u/a/d 4/23/99.
  • The sales produced $12,817,571 at per-share prices of $1,260.3385 to $1,271.63; the underlying options were exercised at $50.92 to $66.47 per share, costing $521,255 in total.
  • TransDigm reported preliminary quarterly results, completed roughly $2.2 billion in acquisitions, and priced $1.5 billion in new debt, including $500 million of 6.125% Senior Subordinated Notes due 2034.

W. Nicholas Howley, a director at TransDigm Group INC (NASDAQ:TDG), executed a series of option exercises and share sales on April 20, 2026, resulting in the disposition of 10,132 common shares and cash proceeds of approximately $12.8 million. The transactions were carried out indirectly through the W. Nicholas Howley Family Trust u/a/d 4/23/99.

The stock sales generated total proceeds of $12,817,571, at per-share sale prices ranging from $1,260.3385 to $1,271.63. Those share dispositions followed the exercise of options on the same 10,132 shares, which were acquired at exercise prices between $50.92 and $66.47 per share. The aggregate cost to exercise those options was $521,255. The exercise prices cited reflect adjustments for dividends declared since August 1, 2022.

Following the exercise-and-sale sequence, the family trust now indirectly owns 21,547.513 shares of TransDigm Group common stock. At the time of the filings referenced in these transactions, TransDigm's market price was quoted at $1,205.67 - below the $1,260 to $1,271 per-share range at which the trust sold shares.

Third-party analysis cited alongside these filings notes that the stock appears to be trading below its intrinsic indication according to InvestingPro, and is near a 52-week low of $1,123.61. That commentary was presented as contextual information and points to where the market price stands relative to recent insider sale levels.


Company financial and corporate activity

In parallel with the insider activity, TransDigm disclosed preliminary financial results for the thirteen-week period ending March 28, 2026. The company estimates net sales in a tight band between $2.54 billion and $2.545 billion, and EBITDA As Defined in a range from $1.33 billion to $1.335 billion. Those figures are preliminary and remain subject to final adjustments.

TransDigm has also completed the acquisitions of Jet Parts Engineering and Victor Sierra Aviation Holdings for a combined consideration of approximately $2.2 billion. The company stated those purchases were funded through a mix of cash on hand and proceeds from debt offerings.

Further financing activity was disclosed: TransDigm priced $1.5 billion in new debt intended to finance its acquisition of Stellant Systems, Inc., and to support share repurchases and related costs. Part of that issuance includes a $500 million offering of 6.125% Senior Subordinated Notes due 2034. The company additionally announced plans for a $1.25 billion debt offering to support its broader financial strategy.

Alongside these moves, Truist has maintained a Buy rating on the company, while noting potential demand pressure stemming from rising oil prices that could affect the aerospace aftermarket. The rating commentary highlights one of the market risks that could influence TransDigm's aftermarket businesses.


Context and positioning

The sequence of option exercises and immediate sales by a director, combined with the ongoing acquisition and financing activity disclosed by TransDigm, presents a clear snapshot of both insider liquidity events and the company’s active capital deployment. The family trust retains a material equity position following the transactions, holding 21,547.513 shares.

Investors and market observers may weigh the director's sales alongside the company’s preliminary quarterly performance, recent M&A activity, and sizeable debt issuances when assessing short-term dynamics in the stock. The available third-party analysis referenced in the filings notes the current trading price relative to historical lows and valuation signals, without extending that commentary into forecasts or recommendations.

All transaction amounts, share counts, price ranges, and financing terms reported here are taken from the disclosures associated with the April 20, 2026 filings and the company’s public announcements.

Risks

  • Market price risk - TransDigm's shares were trading at $1,205.67 at the time noted, below the director's sale range and near a 52-week low of $1,123.61, indicating potential downside volatility in the equity.
  • Operational and demand risk - Rising oil prices were flagged as a potential pressure point that could reduce demand in the aerospace aftermarket sector, per commentary referenced alongside the company's financing and rating updates.
  • Leverage and refinancing risk - The company has undertaken sizeable debt issuances to fund acquisitions and repurchases, which may affect its credit profile and financial flexibility.

More from Insider Trading

Williams-Sonoma CEO Sells $3.0M in Stock Under Prearranged Trading Plan Apr 21, 2026 AEHR Test Systems EVP Vernon Rogers Sells $450,000 in Stock; Company Posts Record Order and Raises Capital Apr 21, 2026 Ouster CTO Disposes of $3.31 Million in Shares After Exercising Options Apr 21, 2026 Opaleye Management Disposes of $336,982 in SANUWAVE Health Stock Across April Trades Apr 21, 2026 Aehr Test Systems Director Sells $843,756 in Stock as Company Posts Record Bookings and Raises Capital Apr 21, 2026